Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Palisade Bio, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 304.0K | 966.1K | +662.1K (+217.8%) |
| Value | $158.3K | $384.6K | +$226.4K (+143.0%) |
New holders (4)
Institutions that held Palisade Bio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 720,000 | $287.4K | 0.01% |
| HRT Financial LP | 32,326 | $12.0K | 0.00% |
| Millennium Management LLC | 18,200 | $7.26K | 0.00% |
| BFSG, LLC | 40 | $16 | 0.00% |
Sold out (4)
Institutions that held Palisade Bio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 54,800 | $32.0K |
| Virtu Financial LLC | 51,928 | $31.0K |
| Warberg Asset Management LLC | 10,000 | $5.90K |
| Northwestern Mutual Wealth Management Co | 1 | $1 |